BeStock  
Stocks › Biotechnology › TSHA

Taysha Gene Therapies TSHA

US equityMarket cap rank #3032Biotechnology
$3.72 −$0.05 (-1.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.71 -0.27%
Open$3.67
Prev close$3.77
Day range$3.60 – $3.80
Volume3.15M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-9.8x
CheapRich

Below its usual level · 22nd percentile, 5-year average -4.8x

Price / book3.7x
CheapRich

Around its usual level · 42nd percentile, 5-year average 4.6x

#4063 of 5330 stocks by PB (1 = cheapest)

Price / sales243.7x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average 71.6x

#5022 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-21x-12x-3x6xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$7.82
Price vs. fair value-52.4%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.74 – 4.56 42% (cheaper than usual) #4063 of 5330 (1 = cheapest)
PE -9.76 -7.32 -4.84 22% (cheaper than usual) –
PS 243.72 524.97 71.60 92% (pricier than usual) #5022 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TSHA.

Sign in to join the discussion.

Scroll to Top